North American Neuromodulation Society

Nalu Medical, Inc. Presents Long-term and Holistic Outcomes from the COMFORT RCT for PNS at NANS 2024

Retrieved on: 
Tuesday, January 23, 2024

The ongoing COMFORT RCT is a randomized, controlled, post-market, open-label, minimal risk, multi-center clinical study focused on evaluating the effectiveness of peripheral nerve stimulation (PNS) therapy with the Nalu Neurostimulation System to treat chronic pain in the shoulder, low back, knee, or ankle/foot.

Key Points: 
  • The ongoing COMFORT RCT is a randomized, controlled, post-market, open-label, minimal risk, multi-center clinical study focused on evaluating the effectiveness of peripheral nerve stimulation (PNS) therapy with the Nalu Neurostimulation System to treat chronic pain in the shoulder, low back, knee, or ankle/foot.
  • The study is designed to develop 3-year data to demonstrate the sustained pain relief and quality of life improvements achievable with the Nalu PNS system.
  • In the COMFORT RCT, we are measuring variables that present this broader picture.
  • “The COMFORT RCT is intended to provide reliable evidence of the sustained effectiveness and impact on quality of life provided by Nalu PNS therapy and to expand the use of Nalu PNS to patients for whom physicians have limited options.

Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting

Retrieved on: 
Wednesday, January 17, 2024

REDWOOD CITY, Calif., Jan. 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the company's HFX™ 10 kHz Therapy for patients with chronic pain. Results will be presented at the 2024 North American Neuromodulation Society (NANS) Annual Meeting held from January 18-21, 2024 at Caesars Palace Las Vegas.

Key Points: 
  • Results will be presented at the 2024 North American Neuromodulation Society (NANS) Annual Meeting held from January 18-21, 2024 at Caesars Palace Las Vegas.
  • A total of 25 scientific abstracts reviewing clinical results for 10 kHz Therapy™, including four podium presentations and 21 posters, will be presented at the conference.
  • "The growing body of clinical evidence from our 25 scientific abstracts displays the substantial benefits of 10 kHz Therapy and we look forward to continuing to treat underserved patient populations suffering from debilitating chronic pain."
  • The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

CENTER FOR PAIN MANAGEMENT WELCOMES DR. JOSHUA WELLINGTON, MD.

Retrieved on: 
Friday, September 1, 2023

INDIANAPOLIS, Sept. 1, 2023 /PRNewswire/ -- Center for Pain Management, together with American Pain Consortium, a leading network of interventional pain practices, is pleased to announce that Joshua Wellington, MD, MS, has joined their practice and will be seeing patients starting September 5, 2023.

Key Points: 
  • INDIANAPOLIS, Sept. 1, 2023 /PRNewswire/ -- Center for Pain Management, together with American Pain Consortium, a leading network of interventional pain practices, is pleased to announce that Joshua Wellington, MD, MS, has joined their practice and will be seeing patients starting September 5, 2023.
  • He will be joining Center for Pain Management to lead the Targeted Drug Delivery program, which will expand patient access to quality care for Intrathecal Pump (ITP) implants.
  • Center for Pain Management, supported by American Pain Consortium, proudly serves Indiana with 7 clinics and 4 Ambulatory Surgery Centers statewide and has been treating a wide range of acute and chronic pain conditions since 1993.
  • The physicians specialize in back pain, neck pain, headache, and joint pain resulting from injuries, arthritis, cancer, fibromyalgia, failed back surgery, Complex Regional Pain Syndromes (CRPS), and other disorders.

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California

Retrieved on: 
Tuesday, May 16, 2023

ROSELAND, N.J., May 16, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables into The Pain and Rehabilitation Medical Group in Torrance, California.

Key Points: 
  • ROSELAND, N.J., May 16, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables into The Pain and Rehabilitation Medical Group in Torrance, California.
  • Dr. Proano initially conducted eight cases using the CompuFlo Epidural system, in which he reported 100% success.
  • The evaluation included Epidural Steroid Injection (ESI) procedures within the lumbar, thoracic and cervical thoracic junction of the spine.
  • Dr. Proano also completed an advanced specialty fellowship in Interventional and Multidisciplinary Pain Management at UCLA Medical Center.

The Inner Circle Acknowledges, Rany T. Abdallah, MD, Ph.D., MBA, as a Most Trusted Healthcare Professional for his contributions to the Medical Field

Retrieved on: 
Wednesday, May 3, 2023

WILMINGTON, Del., May 3, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Rany T. Abdallah, MD, Ph.D., MBA, is acknowledged as a Most Trusted Healthcare Professional for his contributions to the Medical Field.

Key Points: 
  • WILMINGTON, Del., May 3, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Rany T. Abdallah, MD, Ph.D., MBA, is acknowledged as a Most Trusted Healthcare Professional for his contributions to the Medical Field.
  • Dr. Abdallah began his educational journey at the Medical University of South Carolina where he earned a Medical Degree and Doctor of Philosophy degree (Ph.D.).
  • He then completed his residency in anesthesiology at Rush University in Chicago and his fellowship in pain medicine at the University of Pittsburgh, where he served as Chief Fellow.
  • As a pain management specialist, his focus is on pain medicine, evaluation, treatment, and prevention of pain.

American Pain Consortium Acquires Indiana Pain Centers Evansville, a JCAHO accredited Ambulatory Surgery Center.

Retrieved on: 
Monday, January 30, 2023

EVANSVILLE, Ind., Jan. 30, 2023 /PRNewswire/ -- American Pain Consortium (APC) is pleased to announce their latest expansion with the purchase of Indiana Pain Centers Evansville, a JCAHO accredited Ambulatory Surgery Center (ASC) in Evansville, IN.

Key Points: 
  • EVANSVILLE, Ind., Jan. 30, 2023 /PRNewswire/ -- American Pain Consortium (APC) is pleased to announce their latest expansion with the purchase of Indiana Pain Centers Evansville, a JCAHO accredited Ambulatory Surgery Center (ASC) in Evansville, IN.
  • The addition of Indiana Pain Centers Evansville ASC increases the total number of Indiana surgery centers to four and creates access to a larger suite of interventional pain management therapies locally in Evansville.
  • Indiana Pain Centers Evansville ASC is led by Dr. Mansoor Khan who is fellowship trained and board certified in Physical Medicine & Rehabilitation with added qualifications in Interventional Pain Management.
  • This accreditation further demonstrates Indiana Pain Centers Evansville, Center for Pain, and American Pain Consortiums dedication to providing the highest quality of interventional pain care.

Saluda Medical Announces Presentation of 36-Month Trial Data at NANS 2023 Annual Meeting

Retrieved on: 
Tuesday, January 17, 2023

ARTARMON, Australia, Jan. 17, 2023 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced that late-breaking data from the landmark EVOKE Clinical Trial was presented at the 2023 North American Neuromodulation Society (NANS) Annual Meeting. The data presented is the longest follow-up evidence from a US IDE trial in spinal cord stimulation (SCS) history.

Key Points: 
  • ARTARMON, Australia, Jan. 17, 2023 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced that late-breaking data from the landmark EVOKE Clinical Trial was presented at the 2023 North American Neuromodulation Society (NANS) Annual Meeting.
  • The data presented is the longest follow-up evidence from a US IDE trial in spinal cord stimulation (SCS) history.
  • The majority of patients who crossed over from open-loop to closed-loop therapy chose to cross over in search of better pain relief.
  • Importantly, 9 out of 10 patients treated with closed-loop at any time completed the study in the closed-loop arm.

Integer to Exhibit at NANS 2023 Annual Meeting

Retrieved on: 
Tuesday, January 10, 2023

PLANO, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will exhibit at the 26th North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace Convention Center in Las Vegas, Nevada, from Jan. 12 – 14, 2023, joining medtech leaders and innovators from around the world.

Key Points: 
  • PLANO, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will exhibit at the 26th North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace Convention Center in Las Vegas, Nevada, from Jan. 12 – 14, 2023, joining medtech leaders and innovators from around the world.
  • Attendees are invited to visit Integer at booth #525 to learn more about Integer’s breadth and depth of innovative medical device manufacturing, design and development capabilities.
  • This encompasses expanded implantable neuromodulation lead offerings as a result of the acquisition of Oscor in December 2021.
  • During NANS, Integer will unveil its latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable devices.

Rany T. Abdallah, MD, Ph.D., is recognized by Continental Who's Who

Retrieved on: 
Wednesday, January 4, 2023

Dr. Abdallah earned his medical degree and Doctor of Philosophy degree (Ph.D.) at the Medical University of South Carolina.

Key Points: 
  • Dr. Abdallah earned his medical degree and Doctor of Philosophy degree (Ph.D.) at the Medical University of South Carolina.
  • Dr. Abdallah is the Owner/President of APICO Pain Management, serving patients in the Bear, Dover, and Millsboro areas.
  • A pain management specialist is a doctor who specializes in pain medicine, focusing on the evaluation, treatment, and prevention of pain.
  • In his free time, Dr. Abdallah likes to travel and is fluent in English, Arabic, French, and Spanish.

American Pain Consortium Opens a New Fully Accredited Ambulatory Surgery Center in Lafayette, IN

Retrieved on: 
Monday, August 29, 2022

The addition of the Lafayette Surgery Center increases the total number of Indiana surgery centers to three and creates access to interventional pain management locally in Lafayette.

Key Points: 
  • The addition of the Lafayette Surgery Center increases the total number of Indiana surgery centers to three and creates access to interventional pain management locally in Lafayette.
  • Together with the Center for Pain Management (CFP), APC is dedicated to providing exceptional, individualized patient care by world-class, interventional pain physicians.
  • The Lafayette Surgery Center is led by Dr. Joseph Rutledge who is fellowship trained and board certified in Anesthesiology with added qualifications in Pain Management through the American Board of Anesthesiology.
  • Achieving AAAHC Accreditation is proof that Lafayette Surgery Center, Center for Pain Management, & APC have met the rigorous standards of a nationally recognized third party.